Rosuvastatin for primary prevention among individuals with elevated high-sensitivity c-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating R (Q38466546)
Jump to navigation
Jump to search
scientific article published on 24 August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rosuvastatin for primary prevention among individuals with elevated high-sensitivity c-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating R |
scientific article published on 24 August 2010 |
Statements
1 reference
Rosuvastatin for primary prevention among individuals with elevated high-sensitivity c-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating R (English)
1 reference
Wolfgang Koenig
1 reference
Paul M Ridker
1 reference
Robert J Glynn
1 reference
John J P Kastelein
1 reference
Jacques Genest
1 reference
Jean G Macfadyen
1 reference
24 August 2010
1 reference
1 reference
Identifiers
1 reference